157 related articles for article (PubMed ID: 32535624)
1. Effect of anthracycline therapy on myocardial function and markers of fibrotic remodelling in childhood cancer survivors.
Mawad W; Mertens L; Pagano JJ; Riesenkampff E; Reichert MJE; Mital S; Kantor PF; Greenberg M; Liu P; Nathan PC; Grosse-Wortmann L
Eur Heart J Cardiovasc Imaging; 2021 Mar; 22(4):435-442. PubMed ID: 32535624
[TBL] [Abstract][Full Text] [Related]
2. Diffuse myocardial fibrosis by T1-mapping in children with subclinical anthracycline cardiotoxicity: relationship to exercise capacity, cumulative dose and remodeling.
Tham EB; Haykowsky MJ; Chow K; Spavor M; Kaneko S; Khoo NS; Pagano JJ; Mackie AS; Thompson RB
J Cardiovasc Magn Reson; 2013 Jun; 15(1):48. PubMed ID: 23758789
[TBL] [Abstract][Full Text] [Related]
3. Anthracycline-Associated T1 Mapping Characteristics Are Elevated Independent of the Presence of Cardiovascular Comorbidities in Cancer Survivors.
Jordan JH; Vasu S; Morgan TM; D'Agostino RB; Meléndez GC; Hamilton CA; Arai AE; Liu S; Liu CY; Lima JA; Bluemke DA; Burke GL; Hundley WG
Circ Cardiovasc Imaging; 2016 Aug; 9(8):. PubMed ID: 27502058
[TBL] [Abstract][Full Text] [Related]
4. Characterization of subclinical diastolic dysfunction by cardiac magnetic resonance feature-tracking in adult survivors of non-Hodgkin lymphoma treated with anthracyclines.
Barbosa MF; Fusco DR; Gaiolla RD; Werys K; Tanni SE; Fernandes RA; Ribeiro SM; Szarf G
BMC Cardiovasc Disord; 2021 Apr; 21(1):170. PubMed ID: 33845778
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular magnetic resonance characterisation of anthracycline cardiotoxicity in adults with normal left ventricular ejection fraction.
Harries I; Berlot B; Ffrench-Constant N; Williams M; Liang K; De Garate E; Baritussio A; Biglino G; Plana JC; Bucciarelli-Ducci C
Int J Cardiol; 2021 Nov; 343():180-186. PubMed ID: 34454967
[TBL] [Abstract][Full Text] [Related]
6. Ultrahigh-field cardiovascular magnetic resonance T1 and T2 mapping for the assessment of anthracycline-induced cardiotoxicity in rat models: validation against histopathologic changes.
Park HS; Hong YJ; Han K; Kim PK; An E; Lee JY; Park CH; Lee HJ; Hur J; Kim YJ; Choi BW
J Cardiovasc Magn Reson; 2021 Jun; 23(1):76. PubMed ID: 34134713
[TBL] [Abstract][Full Text] [Related]
7. Dynamic Myocardial Response to Exercise in Childhood Cancer Survivors Treated with Anthracyclines.
Cifra B; Chen CK; Fan CS; Slorach C; Manlhiot C; McCrindle BW; Dragulescu A; Redington AN; Friedberg MK; Nathan PC; Mertens L
J Am Soc Echocardiogr; 2018 Aug; 31(8):933-942. PubMed ID: 29615292
[TBL] [Abstract][Full Text] [Related]
8. Myocardial extracellular volume by cardiac magnetic resonance imaging in patients treated with anthracycline-based chemotherapy.
Neilan TG; Coelho-Filho OR; Shah RV; Feng JH; Pena-Herrera D; Mandry D; Pierre-Mongeon F; Heydari B; Francis SA; Moslehi J; Kwong RY; Jerosch-Herold M
Am J Cardiol; 2013 Mar; 111(5):717-22. PubMed ID: 23228924
[TBL] [Abstract][Full Text] [Related]
9. Anthracycline Therapy Is Associated With Cardiomyocyte Atrophy and Preclinical Manifestations of Heart Disease.
Ferreira de Souza T; Quinaglia A C Silva T; Osorio Costa F; Shah R; Neilan TG; Velloso L; Nadruz W; Brenelli F; Sposito AC; Matos-Souza JR; Cendes F; Coelho OR; Jerosch-Herold M; Coelho-Filho OR
JACC Cardiovasc Imaging; 2018 Aug; 11(8):1045-1055. PubMed ID: 30092965
[TBL] [Abstract][Full Text] [Related]
10. Occult cardiotoxicity in childhood cancer survivors exposed to anthracycline therapy.
Toro-Salazar OH; Gillan E; O'Loughlin MT; Burke GS; Ferranti J; Stainsby J; Liang B; Mazur W; Raman SV; Hor KN
Circ Cardiovasc Imaging; 2013 Nov; 6(6):873-80. PubMed ID: 24097420
[TBL] [Abstract][Full Text] [Related]
11. Cardiac magnetic resonance imaging in the evaluation of the late effects of anthracyclines among long-term survivors of childhood cancer.
Ylänen K; Poutanen T; Savikurki-Heikkilä P; Rinta-Kiikka I; Eerola A; Vettenranta K
J Am Coll Cardiol; 2013 Apr; 61(14):1539-47. PubMed ID: 23500246
[TBL] [Abstract][Full Text] [Related]
12. Early detection of myocardial fibrosis in cardiomyopathy in the absence of late enhancement: role of T1 mapping and extracellular volume analysis.
Gao Y; Wang HP; Liu MX; Gu H; Yuan XS; Biekan J; Wang XM
Eur Radiol; 2023 Mar; 33(3):1982-1991. PubMed ID: 36241919
[TBL] [Abstract][Full Text] [Related]
13. Cardiac Involvement in Patients Recovered From COVID-2019 Identified Using Magnetic Resonance Imaging.
Huang L; Zhao P; Tang D; Zhu T; Han R; Zhan C; Liu W; Zeng H; Tao Q; Xia L
JACC Cardiovasc Imaging; 2020 Nov; 13(11):2330-2339. PubMed ID: 32763118
[TBL] [Abstract][Full Text] [Related]
14. CMR-verified diffuse myocardial fibrosis is associated with diastolic dysfunction in HFpEF.
Su MY; Lin LY; Tseng YH; Chang CC; Wu CK; Lin JL; Tseng WY
JACC Cardiovasc Imaging; 2014 Oct; 7(10):991-7. PubMed ID: 25240451
[TBL] [Abstract][Full Text] [Related]
15. Diffuse Myocardial Fibrosis and Inflammation in Rheumatoid Arthritis: Insights From CMR T1 Mapping.
Ntusi NAB; Piechnik SK; Francis JM; Ferreira VM; Matthews PM; Robson MD; Wordsworth PB; Neubauer S; Karamitsos TD
JACC Cardiovasc Imaging; 2015 May; 8(5):526-536. PubMed ID: 25890584
[TBL] [Abstract][Full Text] [Related]
16. Early myocardial oedema can predict subsequent cardiomyopathy in high-dose anthracycline therapy.
Muehlberg F; Kornfeld M; Zange L; Ghani S; Reichardt A; Reichardt P; Schulz-Menger J
ESC Heart Fail; 2023 Feb; 10(1):616-627. PubMed ID: 36404640
[TBL] [Abstract][Full Text] [Related]
17. Myocardial tissue characterization by contrast-enhanced cardiac magnetic resonance imaging in subjects with prediabetes, diabetes, and normal controls with preserved ejection fraction from the general population.
Storz C; Hetterich H; Lorbeer R; Heber SD; Schafnitzel A; Patscheider H; Auweter S; Zitzelsberger T; Rathmann W; Nikolaou K; Reiser M; Schlett CL; von Knobelsdorff-Brenkenhoff F; Peters A; Schulz-Menger J; Bamberg F
Eur Heart J Cardiovasc Imaging; 2018 Jun; 19(6):701-708. PubMed ID: 28950340
[TBL] [Abstract][Full Text] [Related]
18. Diffuse Myocardial Fibrosis and Diastolic Function in Aortic Stenosis.
Lee HJ; Lee H; Kim SM; Park JB; Kim EK; Chang SA; Park E; Kim HK; Lee W; Kim YJ; Lee SC; Park SW; Sohn DW; Oh JK; Park SJ; Lee SP
JACC Cardiovasc Imaging; 2020 Dec; 13(12):2561-2572. PubMed ID: 32828787
[TBL] [Abstract][Full Text] [Related]
19. Left ventricular remodelling in long-term survivors after the arterial switch operation for transposition of the great arteries.
Grotenhuis HB; Cifra B; Mertens LL; Riessenkampff E; Manlhiot C; Seed M; Yoo SJ; Grosse-Wortmann L
Eur Heart J Cardiovasc Imaging; 2019 Jan; 20(1):101-107. PubMed ID: 29800129
[TBL] [Abstract][Full Text] [Related]
20. Myocardial iron load and fibrosis in long term survivors of childhood leukemia.
Cheung YF; Lam WW; Ip JJ; Cheuk DK; Cheng FW; Yang JY; Yau JP; Ho KK; Li CK; Li RC; Yuen HL; Ling AS; Li VW; Chan GC
Pediatr Blood Cancer; 2015 Apr; 62(4):698-703. PubMed ID: 25557466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
